MSB 4.89% $1.07 mesoblast limited

silviu the mastermind, page-2

  1. 5,344 Posts.
    lightbulb Created with Sketch. 956
    I failed to mention in the" management today " article Silviu said "Mesoblast could be offering the world’s first stem cell treatment within three years." that was 2 weeks ago, and since then we have this .......
    Japan’s parliament last week passed a new Bill that legally defines new medical products which contain stem cells as regenerative medicine products. The new law allows the Japanese government to conditionally approve such products if their safety is confirmed in clinical trials.. how things change quickly ... and comments, such as ......(ASX:MSB) separately announced it will be able to use the regulatory pathway to pursue expedited approval of products based on mesenchymal lineage stem and precursor cells. The company plans to establish strategic partnerships with Japanese companies for its products, similar to its existing deal with JCR Pharmaceuticals, to help commercialise a cell-based treatment for steroid-refractory acute graft versus host disease (GvHD)................... Its all coming together rapidly ..Cheers Vin
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.055(4.89%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.14 $1.16 $1.06 $8.816M 8.055M

Buyers (Bids)

No. Vol. Price($)
1 280000 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 2000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.